Business Description
BioVaxys Technology Corp
NAICS : 541714
SIC : 3741
ISIN : CA09076M1014
Share Class Description:
STU:5LB: Ordinary SharesCompare
Compare
Traded in other countries / regions
BIOV.CanadaBVAXF.USA5LB.Germany IPO Date
2020-11-17Description
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | N/A |
N/A
|
N/A
| |||
| Equity-to-Asset | -0.44 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -26 | |||||
| 3-Year EPS without NRI Growth Rate | -26 | |||||
| 3-Year FCF Growth Rate | 10.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 46.88 | |||||
| 12-1 Month Momentum % | -56.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.46 | |||||
| Quick Ratio | 0.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -71.8 | |||||
| Shareholder Yield % | -7.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -1237.15 | |||||
| ROA % | -446.37 | |||||
| ROIC % | -161.2 | |||||
| ROCE % | -313.39 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -3.87 | |||||
| EV-to-EBITDA | -3.87 | |||||
| EV-to-FCF | -9.2 | |||||
| Earnings Yield (Greenblatt) % | -25.81 | |||||
| FCF Yield % | -10.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioVaxys Technology Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.088 | ||
| Beta | 0.4 | ||
| Volatility % | 107.81 | ||
| 14-Day RSI | 46.88 | ||
| 14-Day ATR (€) | 0.000007 | ||
| 20-Day SMA (€) | 0.0088 | ||
| 12-1 Month Momentum % | -56.44 | ||
| 52-Week Range (€) | 0.005 - 0.0262 | ||
| Shares Outstanding (Mil) | 145.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioVaxys Technology Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioVaxys Technology Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioVaxys Technology Corp Frequently Asked Questions
What is BioVaxys Technology Corp(STU:5LB)'s stock price today?
The current price of STU:5LB is €0.01. The 52 week high of STU:5LB is €0.03 and 52 week low is €0.01.
When is next earnings date of BioVaxys Technology Corp(STU:5LB)?
The next earnings date of BioVaxys Technology Corp(STU:5LB) is .
Does BioVaxys Technology Corp(STU:5LB) pay dividends? If so, how much?
BioVaxys Technology Corp(STU:5LB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers